News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2930311234
567891011
12131415161718
19202122232425
2627281234
567891011

Monday, February 27, 2017

Top Breaking News
6 Biotechs Facing Key FDA Decisions in March
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen (BIIB) Alum Michael Gilman
Valeant (VRX)'s Salix (SLXP) Beefs Up Workforce With 250 Sales Reps
6 Biotechs Set Up Shop and Create Jobs in Buffalo, New York
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston
Another Theranos Lab Has Blood-Testing License Revoked
GlaxoSmithKline (GSK) to Shut Down Costa Rica Plant, 150 Jobs Affected
Sanofi (SNY), Lonza Group (LZAGY.PK) Parner Up to Build New $285 Million Swiss Biologics Facility
A Look Inside Takeda (TKPYY)'s Remarkable R&D Transformation
Lawsuit Stalls Sale of Novartis AG (NVS)'s New York Campus
Meet the Woman Developing the Next Generation of Insulin at Novo Nordisk A/S (NVO)
La Jolla Pharma (LJPC)'s Low Blood Pressure Med Meets Phase III Study Goals

News from Around the Web

Press Releases
Is There More Than Meets the Eye On Celgene (CELG)’s President, COO Retirement?
Endo Pharma (ENDP) Issues Voluntary Nationwide Recall For One Lot Of Edex (Alprostadil For Injection) 10 Mcg 2 Pack Carton Due To Potential Lack Of Sterility Assurance
Sunovion Announces Positive Topline Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression
Syros Pharma Reports Discovery Of Novel Genomics Based Approach To Stratifying Patients With Acute Myeloid Leukemia At Cold Spring Harbor Conference
TheraVida, Inc. Announces Publication Of Phase 2 Results For THVD-102 In Hyperhidrosis
Exelixis (EXEL) Announces Clinical Trial Collaboration With Roche To Evaluate Cabozantinib And Atezolizumab In Locally Advanced Or Metastatic Solid Tumors
Medizone Announces The Appointment Of A New Chairman And Interim CEO
Bausch & Lomb And NicOx SA (COX.PA) Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod
AcelRx (ACRX)' New Drug Application For DSUVIA Accepted For Filing With PDUFA Date Of October 12, 2017
AbbVie (ABBV) Receives CHMP Positive Opinion For Eight-Week Treatment Option With VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) For Patients With Genotype 1b Chronic Hepatitis C
RegeneRx Biopharmaceuticals, Inc. (RGRX) Licensee Receives FDA Permission To Conduct A Phase III Trial Of RGN-137 For Epidermolysis Bullosa In U.S.
OncoSec Medical Granted FDA Fast Track Designation For Immunopulse IL-12 For The Treatment Of Metastatic Melanoma Following Progression On Pembrolizumab Or Nivolumab
Sangamo Therapeutics (SGMO) Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome Editing Therapeutic For MPS I
Mederi Therapeutics Inc. Release: Landmark Study: Meta-Analysis Of 28 Studies Shows Stretta Therapy For GERD Consistently And Significantly Improves Outcomes
Case Western Reserve University Release: First Systematic Study Of Deadly, Antibiotic-Resistant Fungus Reported
Exelixis (EXEL) And Bristol-Myers Squibb (BMY) Enter Clinical Collaboration for Late-Stage Combination Trial in First-Line Renal Cell Carcinoma
Bristol-Myers Squibb (BMY) Expands International Immuno-Oncology Network (II-ON) With Addition Of Columbia University Medical Center And Peter MacCallum Cancer Centre
Advaxis (ADXS) And SELLAS Life Sciences Group Announce Licensing Agreement For Development Of WT1 Antigen-Targeting Immunotherapy
CureDuchenne Ventures Invests In New Gene Editing Company Exonics Therapeutics To Advance CRISPR/Cas9 Therapy For Duchenne Muscular Dystrophy
Pharma Two B Ltd. Closes $30 Million Financing Round
Lisa DeFrancesco, Vice President Of Investor Relations, To Leave Allergan (AGN)
AI Predicts Autism By Comparing Babies' Brains, University of North Carolina Study
Scaffolds Covered In Stem Cells And Silver Ions To Prevent Osteomyelitis, University of Missouri Reveals
Veracyte (VCYT): An Ideal Medium-Term Runner With Long-Term Upside
Scientists Test Deep Brain Stimulation As Potential Anorexia Therapy, University of Toronto Study Reveals
Johnson & Johnson (JNJ) Completes Acquisition of Abbott Medical Optics
Bluejay Diagnostics, Inc. Announces Clinical Research Collaboration To Develop Point Of Care Test For Allergic Conjunctivitis

//-->